PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™...

PsyBio Therapeutics to Present at Upcoming Investor Events in September 2022

PT353 – Dr. James Fadiman, Dr. Sam Gandy, & Dr. David...

Psychedelic Bulletin #117 – A Deep Dive Into Psilocybin for Alochol...

Psychedelic Research Bulletin: July and August 2022

Wesana Announces Sale of Clinic Management Services Organization

MDMA Enhances Fear Extinction Learning: From Models to Mechanisms

PT352 – Alex Enchin & Ian-Michael Hébert, MA – HOLOS: Returning...

Algernon Pharmaceuticals Reports Positive Results from Full Data Set of its...

Looking Forward to Horizons Northwest, This September in Portland

Load more